Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

V Duque-Santana, A Diaz-Gavela, M Recio… - World Journal of …, 2023 - Springer
Purpose To analyze the 10-year biochemical relapse-free survival (BRFS), locoregional
relapse-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in …
被引用次数：1 相关文章

Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer.

V Duque-Santana, A Diaz-Gavela, M Recio… - World Journal of …, 2023 - europepmc.org
To analyze the 10-year biochemical relapse-free survival (BRFS), locoregional relapse-free
survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in patients …

Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

V Duque-Santana, A Diaz-Gavela… - World journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose To analyze the 10-year biochemical relapse-free survival (BRFS), locoregional
relapse-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in …